Vaccines

30 June 2020

INOVIO Announces Positive Interim Phase 1 Data For INO-4800 Vaccine for COVID-19

26 June 2020

Entos Pharmaceuticals Announces Selection of Lead DNA Vaccine Candidates for COVID-19 and a $4.2M Award to Move Forward with Phase I/II Human Trials

26 June 2020

ERC Belgium Submits Marketing Authorization Application to European Medicines Agency (EMA) for Glioblastoma Immunotherapy, SITOIGANAP

25 June 2020

Sinovac Receives Approval from China for its Quadrivalent Influenza Vaccine

24 June 2020

Immunovative Therapies and Mirror Biologics Announce US FDA Clearance of a Universal Anti-Viral Vaccine Phase I/II Clinical Trial for Healthy Elderly Adults

23 June 2020

Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas

23 June 2020

First Participant Dosed in Phase 1 Clinical Study with VTP-300 Immunotherapeutic to Treat Chronically Infected Hepatitis B Patients

23 June 2020

Collaborative COVID-19 Vaccine Project Between ImmunoPrecise Antibodies Europe and LiteVax BV, Funded Through TRANSVAC2

22 June 2020

Merck Announces That V114, Its Investigational 15-valent Pneumococcal Conjugate Vaccine, Met Safety and Immunogenicity Objectives in Initial Phase 3 Studies in Adults

22 June 2020

Pfizer Announces Start of Four Phase 3 Clinical Trials for Investigational Vaccines

22 June 2020

VBI Vaccines Announces Data from VBI-1901 Presented at AACR 2020: Partial Response Observed, Promising Biomarker Strategy Identified

22 June 2020

50% Complete Response Rate Observed in YourVaccx™ Study for Patients with Metastatic Prostate Cancer was Presented at the AACR Virtual Annual Meeting II

20 June 2020

Clover Biopharmaceuticals Initiates Phase 1 Clinical Trial for COVID-19 Vaccine Candidate

18 June 2020

Codagenix Announces the Synthesis and Preliminary Safety of Scalable, Live-attenuated Vaccine Candidate Against COVID-19

18 June 2020

CureVac Receives Regulatory Approval from German and Belgian Authorities to Initiate Phase 1 Clinical Trial of its SARS-CoV-2 Vaccine Candidate

17 June 2020

HOOKIPA Announces FDA Clearance of its IND Application for HB-202/201 Clinical Trial to Treat HPV-Positive Cancers

17 June 2020

PDS Biotechnology and Farmacore Biotechnology Announce Co-Development of PDS0204 COVID-19 Vaccine

16 June 2020

Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine

16 June 2020

Immunomic Therapeutics Enters into License Agreement with Ichor Medical Systems to Use Electroporation (EP) Delivery Technology in Phase I Study of DNA Vaccine Therapy, ITI-1001

16 June 2020

Government-funded Imperial College COVID-19 vaccine moves into first human trials

15 June 2020

Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate

15 June 2020

Treos Bio Forms New Subsidiary to Develop a Preventive COVID-19 Peptide Vaccine

15 June 2020

ATUM and Phylex BioSciences Collaborate to Accelerate the Development of a Universal SARS Coronavirus Vaccine

15 June 2020

Batavia Biosciences and Valneva Collaborate to Accelerate Development of Low-cost Inactivated Polio Vaccine

14 June 2020

AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit

14 June 2020

Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19

13 June 2020

Calquence showed long-term efficacy and tolerability for patients with chronic lymphocytic leukaemia in two trials

13 June 2020

FDA Approves Merck’s GARDASIL 9 for the Prevention of Certain HPV-Related Head and Neck Cancers

11 June 2020

Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19

11 June 2020

Sinovac and Butantan Join Efforts to Advance the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III

News Channels

Newsletter

La Merie Biologics

La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.

Newsletter La Merie Biologics

Newsletter

New Product Alert

La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.

Newsletter new product alert

Featured reports

Vectorized Antibodies for In Vivo Expression by DNA and mRNA: a landscape analysis of stakeholders, technologies, targets, business and financing from an industry perspective

2022 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics

TROP-2-Targeted Immunotherapy Pipeline Review

2FOR1 Report Package: Vectorized Antibody and Prodrug Antibody & Cytokine landscape analysis report package with 50% discount

CD40 Agonists & CD40/L Antagonists Pipeline Review

Blockbuster Biologics 2018: Sales of Recombinant Therapeutic Antibodies & Proteins

Folate Receptor alpha (FRα) Targeted Therapy Pipeline Review

Claudin 18.2-Targeted Immunotherapeutics – a Competitor Analysis

CD38-Targeted Antibody & Cell Therapy Pipeline Review

Tocilizumab (Actemra/RoActemra) Biosimilar Antibody Pipeline Review